16.5 Gastrointestinal & Hepatobiliary Infections: Fulminant C. difficile, Typhlitis, CMV Colitis & Abscesses
Key Takeaways
Fulminant Clostridioides difficile infection is treated with vancomycin 500 mg four times daily enterally plus intravenous metronidazole 500 mg every 8 hours, with rectal vancomycin added when ileus is present.
Surgical options for fulminant C. difficile infection are subtotal colectomy with end ileostomy, or diverting loop ileostomy with colonic lavage, and should be considered before multiorgan failure is established.
Neutropenic enterocolitis (typhlitis) is managed medically with bowel rest, broad-spectrum antibiotics covering gram-negative bacteria and anaerobes, and surgery only for perforation or uncontrolled bleeding.
Spontaneous bacterial peritonitis is diagnosed by an ascitic neutrophil count of at least 250 cells/µL and is treated with a third-generation cephalosporin plus albumin 1.5 g/kg then 1 g/kg on day 3.
Amebic liver abscess is usually a single right-lobe lesion treated with metronidazole plus a luminal agent, without drainage unless it is very large, left-lobed, or fails to respond.
Fulminant Clostridioides difficile Infection
Severity grading:
- Non-severe: white cell count below 15,000/µL and creatinine below 1.5 mg/dL.
- Severe: white cell count of 15,000/µL or more, or creatinine of 1.5 mg/dL or more.
- Fulminant: hypotension or shock, ileus, or toxic megacolon.
Clues in the ICU: a very high white cell count (sometimes above 40,000/µL), a rising lactate, paradoxically absent diarrhea when ileus develops, abdominal distension with a dilated colon on imaging (a transverse colon diameter above 6 cm), and marked hypoalbuminemia from protein-losing colopathy.
Treatment of fulminant disease:
- Vancomycin 500 mg enterally four times daily (oral or by nasogastric tube).
- Plus intravenous metronidazole 500 mg every 8 hours.
- Plus rectal vancomycin (500 mg in 100 mL saline as a retention enema every 6 hours) when ileus prevents enteral delivery.
- Fidaxomicin is preferred for non-fulminant disease (it lowers recurrence) but has less data in fulminant disease.
- Stop the inciting antibiotic if possible, avoid antimotility agents, and avoid proton pump inhibitors where feasible.
- Bezlotoxumab reduces recurrence in selected high-risk patients; fecal microbiota-based therapy is for recurrent, not fulminant, disease.
- Surgery: involve surgery early. Options are subtotal colectomy with end ileostomy or diverting loop ileostomy with colonic lavage and antegrade vancomycin. Indications include perforation, megacolon, worsening organ failure, and failure of medical therapy; operating after multiorgan failure is established carries very high mortality. A rising lactate (above about 5 mmol/L) and a white cell count above 50,000/µL mark poor prognosis.
Neutropenic Enterocolitis (Typhlitis)
- Host: profound neutropenia after induction chemotherapy, typically 1 to 2 weeks after cytotoxic therapy.
- Presentation: fever, right lower quadrant pain, diarrhea (sometimes bloody), and distension. Mortality is high.
- Imaging: CT shows cecal and ascending colon wall thickening (above about 4 mm), pericolic fat stranding, and sometimes pneumatosis.
- Management is medical: bowel rest, nasogastric decompression if obstructed, intravenous fluid, and broad-spectrum antibiotics covering enteric gram-negative bacteria, anaerobes, and Pseudomonas (piperacillin-tazobactam or a carbapenem). Add antifungal therapy for persistent fever. Transfuse for cytopenias; G-CSF is often used to accelerate recovery.
- Avoid antimotility agents, routine colonoscopy (perforation risk), and rectal examinations.
- Surgery is reserved for perforation, uncontrolled bleeding, or clinical deterioration despite maximal therapy. Distinguish it from C. difficile colitis and from appendicitis.
CMV Colitis and Other Viral Gastrointestinal Disease
- Host: transplant recipients, advanced HIV, and patients on steroids or biologics; CMV also complicates severe ulcerative colitis.
- Presentation: diarrhea (often bloody), abdominal pain, fever, and sometimes perforation or massive bleeding.
- Diagnosis: endoscopy with biopsy showing inclusion bodies and positive immunohistochemistry; blood CMV PCR can be negative in isolated gastrointestinal disease.
- Treatment: intravenous ganciclovir (then valganciclovir), reduce immunosuppression where possible, and monitor for neutropenia. Foscarnet for resistant or ganciclovir-intolerant disease.
- Other causes: norovirus outbreaks in units, adenovirus in transplant recipients, HSV esophagitis, and Candida esophagitis in immunocompromised hosts.
Liver and Biliary Infections
| Condition | Features | Management |
|---|---|---|
| Pyogenic liver abscess | Fever, right upper quadrant pain, elevated alkaline phosphatase; polymicrobial from biliary or portal sources; Klebsiella pneumoniae invasive syndrome (often with metastatic infection including endophthalmitis) | Percutaneous drainage plus antibiotics (a beta-lactam-beta-lactamase inhibitor or a cephalosporin plus metronidazole) for 4 to 6 weeks; look for a colonic source |
| Amebic liver abscess | Travel or residence in an endemic area; usually a single right-lobe lesion; positive Entamoeba histolytica serology; "anchovy paste" contents without organisms | Metronidazole (or tinidazole) plus a luminal agent (paromomycin); drainage only for very large lesions, left-lobe lesions threatening pericardial rupture, uncertain diagnosis, or failure to improve |
| Acute cholangitis | Charcot triad (fever, jaundice, right upper quadrant pain); Reynolds pentad adds hypotension and confusion | Antibiotics plus urgent biliary decompression (ERCP, or percutaneous transhepatic drainage) |
| Acute cholecystitis and acalculous cholecystitis | Acalculous disease occurs in critically ill, fasting patients on vasopressors or parenteral nutrition; ultrasound shows wall thickening, sludge, and pericholecystic fluid | Antibiotics plus percutaneous cholecystostomy in patients who cannot tolerate surgery |
| Infected pancreatic necrosis | Usually after the first week; gas in the collection, clinical deterioration | Antibiotics with good pancreatic penetration (carbapenem, or a fluoroquinolone plus metronidazole) and a step-up approach: percutaneous or endoscopic drainage first, then minimally invasive necrosectomy; delay intervention beyond about 4 weeks when possible. Prophylactic antibiotics for sterile necrosis are not recommended |
| Spontaneous bacterial peritonitis | Cirrhosis with ascites; fever, pain, encephalopathy, or kidney injury, sometimes without symptoms | Diagnostic paracentesis with an ascitic neutrophil count of 250 cells/µL or more; third-generation cephalosporin plus albumin 1.5 g/kg on day 1 and 1 g/kg on day 3 to prevent kidney injury; secondary prophylaxis with norfloxacin or trimethoprim-sulfamethoxazole |
| Secondary bacterial peritonitis | Polymicrobial, very high protein and LDH in ascites, low glucose; a perforation | Imaging and surgical source control (antibiotics alone fail) |
Other Intra-Abdominal Infections to Recognize
- Diverticulitis with perforation: Hinchey III and IV disease needs operative management; abscesses larger than about 3 to 4 cm are drained percutaneously.
- Emphysematous cholecystitis and pyelonephritis: gas-forming infection in diabetes, with high mortality; urgent drainage or surgery.
- Appendicitis in the ICU: often delayed and perforated at presentation.
- Ogilvie syndrome with colonic ischemia: distinguish mechanical obstruction from pseudo-obstruction before giving neostigmine.
- Enteric fever and Yersinia: travel or ileocecal disease that mimics appendicitis.
Note
Any intra-abdominal infection that is not improving within 48 to 72 hours of appropriate antibiotics implies inadequate source control. Reimage and reintervene rather than broadening antibiotics reflexively.
A 68-year-old woman 10 days into treatment for pneumonia develops abdominal distension, hypotension requiring norepinephrine, a white cell count of 46,000/µL, a lactate of 4.8 mmol/L, and absent bowel sounds without diarrhea. CT shows diffuse colonic wall thickening with a transverse colon diameter of 8 cm, and stool testing is positive for Clostridioides difficile toxin. Which initial regimen is most appropriate?
Oral fidaxomicin 200 mg twice daily alone
Intravenous metronidazole alone with loperamide for symptom control
Enteral vancomycin 500 mg four times daily plus intravenous metronidazole plus rectal vancomycin, with early surgical consultation
Oral vancomycin 125 mg four times daily with a fecal microbiota transplant within 24 hours
A 34-year-old man with acute myeloid leukemia has an absolute neutrophil count of 90/µL nine days after induction chemotherapy. He develops fever, right lower quadrant pain, and watery diarrhea. CT shows cecal wall thickening of 9 mm with pericolic stranding and no free air. C. difficile testing is negative. What is the most appropriate management?
Bowel rest with broad-spectrum antibiotics covering gram-negative bacteria, anaerobes, and Pseudomonas
Urgent right hemicolectomy to prevent perforation
Colonoscopy with biopsies to establish the diagnosis before starting antibiotics
Loperamide for symptom control with oral ciprofloxacin
A 56-year-old man with alcohol-associated cirrhosis presents with worsening encephalopathy and a creatinine rise from 0.9 to 1.6 mg/dL. He has no abdominal pain and is afebrile. Diagnostic paracentesis shows 620 neutrophils/µL with a total protein of 0.8 g/dL. Which management is most appropriate?
Ceftriaxone alone, reserving albumin for patients with abdominal pain or fever
Ceftriaxone plus intravenous albumin 1.5 g/kg on day 1 and 1 g/kg on day 3
Immediate exploratory laparotomy for secondary bacterial peritonitis
Oral norfloxacin as definitive treatment with repeat paracentesis in 1 week
Sections you finish are checked off in the contents.